Concord Biotech Limited has informed the Exchange regarding Resignation of Mr Lalit Sethi as Chief Financial Officer of the company w.e.f. January 05, 2026.
CONCORDBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Concord Biotech Limited has informed the stock exchange that Mr. Lalit Sethi has resigned as the Chief Financial Officer of the company. His resignation will take effect from January 5, 2026. No reasons for the resignation or details about a successor have been mentioned in the filing. The company will need to appoint a new CFO to fill this key leadership role.
CFO resignations can create short-term uncertainty around financial reporting and strategic continuity. Investors should watch for announcements regarding a replacement CFO, as the leadership transition could influence investor sentiment.